Consumer Healthcare Products Association
FDARulemakingFDA-2025-N-1360

Over-the-Counter Monograph Procedure for Minor Changes C001: Minor Changes to Solid Oral Dosage Forms for Certain Over-the-Counter Monograph Drugs

RIN
Last modified
Oct 9, 2025
Comment window
closed 298d ago
Consumer Healthcare Products Association filings
1

Activity

Consumer Healthcare Products Association filed 1 comment on this docket between Oct 9, 2025 and Oct 9, 2025. 1 other organizations filed here. The comment window closed 298d ago.

What Consumer Healthcare Products Association filed (1)

Oct 9, 2025· Comment from Consumer Healthcare Products Association (CHPA)· FDA-2025-N-1360-0007

Please find attached comments from the Consumer Healthcare Products Association

Abstract

The Food and Drug Administration (FDA) is announcing the availability on its website of the proposed administrative order (proposed order) (OTC000038) entitled “Over-the-Counter Monograph Procedure for Minor Changes C001: Minor Changes to Solid Oral Dosage Forms for Certain Over-the-Counter Monograph Drugs.” This proposed order, if finalized, will permit minor changes in the dosage form, i.e., from tablets and capsules to chewable tablets, orally disintegrating tablets, or films, of over-the-counter (OTC) monograph drugs that are in conformity with the requirements of the order, the Federal Food, Drug, and Cosmetic Act (FD&C Act), and other applicable requirements, without the issuance of a separate order amending an applicable OTC monograph to add the new dosage form or otherwise finding the new dosage form to be generally recognized as safe and effective (GRASE).

View on regulations.gov →
Over-the-Counter Monograph Procedure for Minor Changes C001: Minor Changes to Solid Oral Dosage Forms for Certain Over-the-Counter Monograph Drugs (FDA) — Consumer Healthcare Products Association | OpenPolis